|
Mr. Dolan has been investing in life sciences companies for the last twenty years as a founding partner in Charter Venture Capital. He has been an active founder of multiple life sciences companies, including the women's health company Adeza Biomedical, cardiac catheter company EP Technologies (IPO, then acquired by Boston Scientific), biotech company Heska Corporation (HSKA), biotech company Univax Biologics (IPO, then acquired by NABI), women's health drug delivery company UMD and women's health medical device company Vesta (acquired by Pfizer). Among his many roles with these companies, Mr. Dolan has also served as interim chief executive officer of Adeza and EP Technologies and chairman of several others. | 